NOT-CA-24-024: Notice of Correction to PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)

Notice of Correction to PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)

Notice Number:

NOT-CA-24-024

Key Dates

Release Date:

January 4, 2024

Related Announcements

October 5, 2023 - Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional). See NOFO PAR-23-308

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Application Types Allowed in PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional).

The following section of PAR-23-308 has been corrected - the correction is indicated by bold italics:

Part 2. Full Text of Announcement, Section II. Award Information

Currently, it reads:

Application Types Allowed:

New
Renewal - (Renewals allowed for applications that were awarded under PAR-22-249)
Resubmission

Corrected to read:

New
Renewal
Resubmission

All other aspects of PAR-23-308 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Sandra L. San Miguel-Majors, DrPH, M.S.
National Cancer Institute (NCI)
Telephone: 240-276-5977
Email: sandra.sanmiguel@nih.gov

Behrous Davani, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: behrous.davani@nih.gov

LeeAnn Bailey, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: leeann.bailey@nih.gov

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov

Financial/Grants Management Contact(s)

Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 202-276-5699
Email: Dawn.Mitchum@nih.gov